Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

November 01, 1993; Volume 267,Issue 2
  • You have access
    Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.
    F Qadri, J Culman, A Veltmar, K Maas, W Rascher and T Unger
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 567-574;
  • You have access
    Mechanism of flecainide's rate-dependent actions on action potential duration in canine atrial tissue.
    Z Wang, B Fermini and S Nattel
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 575-581;
  • You have access
    3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.
    R W Kuncl, D B Drachman, R Adams and M Lehar
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 582-589;
  • You have access
    Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.
    S Giuliani, R Patacchini, G Barbanti, D Turini, P Rovero, L Quartara, A Giachetti and C A Maggi
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 590-595;
  • You have access
    Bronchopulmonary actions of 1-(1,2,3,4-tetrahydro-1-naphthylenyl)-1H-imidazole, nitric acid salt (LY150310), a substituted imidazole, in the guinea pig.
    P W Stengel, R D Dillard, H L Cho, D W Snyder, S M Spaethe, P A Pechous, R L Obenchain, S L Cockerham and S A Silbaugh
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 596-603;
  • You have access
    Aminopyridine block of potassium channels in mouse neuroblastoma cells.
    J K Hirsh and F N Quandt
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 604-611;
  • You have access
    Calcium channel blockers inhibit hydrogen peroxide-induced proliferation of cultured rat mesangial cells.
    I Duque, M Rodriguez Puyol, P Ruiz, M Gonzalez-Rubio, M L Diéz Marques and D Rodriguez Puyol
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 612-616;
  • You have access
    Tamoxifen and vanadate synergize in causing accumulation of polyphosphoinositides in GH4C1 membranes.
    Z Y Friedman
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 617-623;
  • You have access
    Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
    E C Strain, K L Preston, I A Liebson and G E Bigelow
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 624-634;
  • You have access
    Delta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila.
    T W Klein, C Newton, R Widen and H Friedman
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 635-640;
  • You have access
    EXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist.
    P C Wong, J V Duncia, A T Chiu, R E Olson, D H Rominger, S W Tam and P B Timmermans
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 641-647;
  • You have access
    RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    L B Katz, E C Giardino, J J Salata, J B Moore and R Falotico
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 648-656;
  • You have access
    Angiotensin II receptor blockade improves renal function in rats with reduced renal mass.
    D M Pollock, B J Divish, J S Polakowski and T J Opgenorth
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 657-663;
  • You have access
    NPC 15669 reduces mortality associated with sepsis in rats.
    L Noronha-Blob, V C Lowe, L Otterbein, L Steranka and R M Burch
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 664-669;
  • You have access
    Role of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats.
    J H Lin, I W Chen, F A deLuna and M Hichens
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 670-675;
  • You have access
    Renovascular actions of angiotensin II in the isolated kidney of the rat: relationship to lipoxygenases.
    C P Bell-Quilley, Y S Lin, S D Hilchey, E D Drugge and J C McGiff
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 676-682;
  • You have access
    A selective agonist of endothelin type B receptor, IRL 1620, stimulates cyclic GMP increase via nitric oxide formation in rat aorta.
    Y Fujitani, H Ueda, T Okada, Y Urade and H Karaki
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 683-689;
  • You have access
    Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier.
    W A Banks, A J Kastin, G Komaki and A Arimura
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 690-696;
  • You have access
    Enrichment for metallothionein does not confer resistance to cisplatin in transfected NIH/3T3 cells.
    K A Morton, B J Jones, M H Sohn, F L Datz and R E Lynch
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 697-702;
  • You have access
    Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids.
    I Szabo, M Rojavin, J L Bussiere, T K Eisenstein, M W Adler and T J Rogers
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 703-706;
  • You have access
    Differential regulation of neuropeptide Y systems in limbic structures of the rat.
    L P Midgley, L G Bush, J W Gibb and G R Hanson
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 707-713;
  • You have access
    Facilitated dissociation of albumin-fatty acid complexes by rat hepatocytes.
    F J Burczynski, J B Moran and Z S Cai
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 714-719;
  • You have access
    Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.
    L L Simpson, J A Coffield and N Bakry
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 720-727;
  • You have access
    Competitive inhibition by capsazepine of [3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat.
    A Szallasi, C Goso, P M Blumberg and S Manzini
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 728-733;
  • You have access
    Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.
    B R Krause, A Black, R Bousley, A Essenburg, J Cornicelli, A Holmes, R Homan, K Kieft, C Sekerke and M K Shaw-Hes
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 734-743;
  • You have access
    Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine.
    J A Kline, C A Tomaszewski, J D Schroeder and R M Raymond
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 744-750;
  • You have access
    Transport of 2,4,5-trichlorophenoxyacetic acid across the blood-cerebrospinal fluid barrier of the rabbit.
    C S Kim and J B Pritchard
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 751-757;
  • You have access
    Mechanism-based inactivation of cytochrome P450 1A1 by N-aralkyl-1-aminobenzotriazoles in guinea pig kidney in vivo and in vitro: minimal effects on metabolism of arachidonic acid by renal P450-dependent monooxygenases.
    L C Knickle, C D Webb, A A House and J R Bend
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 758-764;
  • You have access
    Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    S Rosenzweig-Lipson and J Bergman
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 765-775;
  • You have access
    Effects of nicotine on neocortical electrical activity in rats.
    P Riekkinen, M Riekkinen and J Sirviö
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 776-784;
  • You have access
    Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.
    T Suzuki, F Nantel, H Bonin, M Valiquette and M Bouvier
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 785-790;
  • You have access
    Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    R K Zalups
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 791-800;
  • You have access
    Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
    S Jin, B Johansson and B B Fredholm
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 801-808;
  • You have access
    Prevention of experimental carotid artery thrombosis by applaggin.
    W E Rote, D X Mu, R A Roncinske, A L Frelinger and B R Lucchesi
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 809-814;
  • You have access
    Types A and B monoamine oxidase contribute to the metabolism of norepinephrine in perfused lungs of rats.
    N N Westwood and L J Bryan-Lluka
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 815-821;
  • You have access
    Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
    M Ogidigben, T C Chu and D E Potter
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 822-827;
  • You have access
    Differential attenuation of the responses to adenosine and methoxamine in isolated rabbit aorta.
    H L Wiener and G P Thalody
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 828-837;
  • You have access
    Caffeine withdrawal: apparent heterologous sensitization to adenosine and prostacyclin actions in human platelets.
    S Paul, B Kurunwune and I Biaggioni
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 838-843;
  • You have access
    Anticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain.
    A Concas, G Santoro, M P Mascia, E Maciocco, L Dazzi, E Ongini and G Biggio
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 844-851;
  • You have access
    A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.
    K J Chang, G C Rigdon, J L Howard and R W McNutt
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 852-857;
  • You have access
    Antinociceptive actions of BW373U86 in the mouse.
    K D Wild, J McCormick, E J Bilsky, T Vanderah, R W McNutt, K J Chang and F Porreca
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 858-865;
  • You have access
    Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.
    S D Comer, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H Woods
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 866-874;
  • You have access
    A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration.
    L A Dykstra, G M Schoenbaum, J Yarbrough, R McNutt and K J Chang
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 875-882;
  • You have access
    A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
    P H Lee, R W McNutt and K J Chang
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 883-887;
  • You have access
    Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.
    S D Comer, E M Hoenicke, A I Sable, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H Woods
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 888-895;
  • You have access
    Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.
    S S Negus, T F Burke, F Medzihradsky and J H Woods
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 896-903;
  • You have access
    Effects of naftidrofuryl on hypoxia-induced activation and mortality of human endothelial cells.
    C Michiels, T Arnould, D Janssens, I Alexandre, A Houbion and J Remacle
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 904-911;
  • You have access
    Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
    D Jackson, E D Abercrombie and M J Zigmond
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 912-918;
  • You have access
    Insulin-like growth factor-I ameliorates transient ischemia-induced acute renal failure in rats.
    S Noguchi, Y Kashihara, Y Ikegami, K Morimoto, M Miyamoto and K Nakao
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 919-926;
  • You have access
    Enhanced expression of rat hepatic CYP2B1/2B2 and 2E1 by pyridine: differential induction kinetics and molecular basis of expression.
    H Kim, D Putt, S Reddy, P F Hollenberg and R F Novak
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 927-936;
  • You have access
    A study of the dose dependency of a glycine receptor antagonist in focal ischemia.
    J Chen, S Graham, F Moroni and R Simon
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 937-941;
  • You have access
    Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.
    M A Hurni, A B Noach, M C Blom-Roosemalen, A G de Boer, J F Nagelkerke and D D Breimer
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 942-950;
  • You have access
    Microvascular substance P binding to normal and inflamed rat and human synovium.
    D A Walsh, M Salmon, P I Mapp, J Wharton, N Garrett, D R Blake and J M Polak
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 951-960;
  • You have access
    [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.
    D W Bonhaus, D N Loury, L B Jakeman, Z To, A DeSouza, R M Eglen and E H Wong
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 961-970;
  • You have access
    Autoradiographic distribution of [14C]tetrahydrobiopterin and its developmental change in mice.
    M Hoshiga, K Hatakeyama, M Watanabe, M Shimada and H Kagamiyama
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 971-978;
  • You have access
    Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig.
    J F Regal, D G Fraser and C A Toth
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 979-988;
  • You have access
    Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
    D B Vinh and R S McIvor
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 989-996;
  • You have access
    Correlation between insulin receptor occupancy and tyrosine kinase activity at low insulin concentrations and effect of major histocompatibility complex class I-derived peptide.
    J Stagsted, T Hansen, R A Roth, A Goldstein and L Olsson
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 997-1001;
  • You have access
    Serotonin-induced muscle contraction in rat stomach fundus is mediated by a G alpha z-like guanine nucleotide binding protein.
    H Y Wang, K Eberle-Wang, K J Simansky and E Friedman
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 1002-1011;
  • You have access
    Identification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase.
    S Imaoka, P J Wedlund, H Ogawa, S Kimura, F J Gonzalez and H Y Kim
    Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 1012-1016;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 267, Issue 2
1 Nov 1993
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Nose-to-Brain Delivery
  • Interaction between Bupropion and MDMA
  • Smoking Could Worsen COVID-19 Outcome
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics